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From retrospective review of imaging studies of patients
who required emergency surgery after ADTAD in this
series, most patients could have been treated with endovas-
cular grafts, whichmight have improved outcomes. Further
clinical studies are needed to carefully assess the value of
endovascular stent grafting in the treatment of patients
requiring emergency intervention for ADTAD and the
need for endovascular stent grafting in patients with un-
complicated ADTAD.
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Dr Walter McCarthy (Chicago, Ill). Tell us now what you
have done as far as using endovascular techniques. What is your
protocol at this point? You have gone back over your data. You
have convinced yourself that youmight be able to use it. What have
you done?
Dr Girma Tefera. Thank you for the question. Since we
reviewed this data we have a protocol in place to treat an endovas-
cular patient who may present with complications requiring sur-
gery. In fact, we recently had a case of acute type B dissection with
occlusion of the aorta at the celiac artery. This patient presented
with paraplegia, anuria, and abdominal pain. We were able to open
the true lumen with balloon mounted palmaz stents deployed
across the occluded segment. Although this procedure temporarily
was successful, it reoccluded 48 hours later. The patient was then
taken to surgery for aortic replacement. Intravascular ultrasound
was very helpful in identifying the true lumen. If I am faced with a
similar situation, I will probably try to address the proximal tear
also with covered stent graft.
Dr Michael Dalsing (Indianapolis, Ind). Very nice paper, Drrepair makes things worse and that you have to operate on them
more quickly than if they do not?
Dr Tefera. The short answer to your question is, I do not
know. It is, however, interesting that this same phenomenon was
observed during thoracic endograft trials. This may have some-
thing to do with the absence of lumbar arteries in the infrarenal
aorta.
Dr JohnMatsumura (Chicago, Ill). I don’t know about why
open repair might make it risky, but I have noticed in the patients
who have an endovascular infrarenal repair who develop a thoracic
dissection that it is a very lethal combination because it tries to
stent open the true lumen, and because both legs feed off the true
lumen, oftentimes the legs create a huge outflow and increase the
chance for true lumen collapse. Roy, have you seen patients after
infrarenal repair who have type B dissection? I have seen two cases
where it is a very bad combination.
Unidentified speaker. We wrote up one case after an en-
dograft with an aortic dissection where the fixation and the seal in
the iliacs was so much stronger so that the false lumen kind of
terminates in the aneurysm sac and crushed the endograft itself.
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have not seen a lot of dissections in those endo repair patients,
infrarenal endo repairs, or open repair patients. I mean, I have
always viewed open repair as a little bit protective of dissection
because it always prevents the dissection from going down to the
iliacs but I do not know. Your data are very interesting.
Unidentified speaker.We have seen two patients with aortic
occlusion who had infrarenal aortic aneurysms and later dissection.
One was an endograft and one was a standard repair. I think it can
occur with either patient. Both were successfully treated for their
aortic occlusion with fenestration and revision. The endograft we
had to explant which was kind of a chore in the fact of an acute
dissection but it was able to be done.
Dr Jacobs–Don v Chad. I would question your conclusion.
One of them was that we should not be treating ______ currently
______ with an endograft. I am not arguing that point, but I am
not sure that your data would say that because we do not know
what they die of. With your survival curve there looking pretty
steep on these patients, I think you would have to knowwhat those
complications potentially of the dissection are down the line that
you may be able to prevent. That may be the mortality that you are
seeing in your survival group.
Dr Tefera. I think the point I indirectly wanted to make was
when you are successful treating these patients medically the
mortality rate of 1.6 is very hard to argue with because when you
see stent graft placement in dissection settings, high technical
success is reported but the mortality rate is not that low yet. That is
why I question and basically want to bring this point up, but I think
when we followed our patients, about a third them do require
elective surgery for further aneurysm expansion. We did not go
specifically to see of those who died during follow-up why they
died, but you also saw that from the curve point of view the 1-year
survival was 85% when they were successfully medically treated.Dr Roy Greenberg (Cleveland, Ohio). I think that your
results are right on in terms of the low mortality rate associated
with medical therapy for uncomplicated dissections, but some-
thing that we have struggled with is how to define optimal medical
therapy because it varies so much. So I was wondering if you had a
system for how you looked at patients. When was medical therapy
optimal and what was the drug regimen? Were they always beta-
blockers? Did you combine beta-blockers with ACE inhibitors?
How did you manage those patients?
Dr Tefera. At our institution all patients who come in with
type B dissection come to the Vascular Surgery Service, and we
basically admit all of them. Unless there is a life-threatening,
limb-threatening situation that needs to go to the operating room,
these patients will all go to the intensive care unit, have an arterial
line placed, and we have preprinted orders for esmolol drips and
nitroglycerin to be started right away. On top of that, we start of a
course oral medications to supplement. We take actually several
days of ICU stabilization prior to these patients being transferred
to the floor. In fact, if you look at the hospital length of stay for
successful medical therapy patients, it is almost the same as for
those who needed surgery. We take really our time and we have
liberal usage of the maximum dosage of esmolol and nitroglycerin,
and occasionally nitroprusside, and we transition them as quickly as
possible into an oral regimen.
Of course they all go home with a lot more oral medication
than what they had before, and we communicate with the primary
care physicians prior to their being discharged. We really take total
control, and of course medical therapy might be a failure some-
times, but it does not really occur in terms of not being able to
control the blood pressure, particularly, if you have a pseudocoarc-
tation kind of picture is rare certainly and by having these patients
on your service I think helps.
